WASHINGTON — Chuck Grassley wasted little time this week in unveiling his drug-pricing agenda, attaching his name to a trio of bills that, as the new chair of the Senate Finance Committee, he is freshly empowered to advance.
Grassley, an Iowa Republican, was among the many lawmakers who hurried to announce bills to lower drug costs, many of which have stalled in past sessions but that now enjoy renewed enthusiasm, as President Trump and Democrats on Capitol Hill continue their pharmaceutical industry focus.
About the Author Reprints
Great story. I will be contacting members of Congress who seek to lower drug prices. I’m hoping that they address the following: People like me can’t participate in a discount program offered by a manufacturer if they get government aid like Medicare. I could be receiving a drug I really need that costs $1,000 a month for $15.
I always wonder why these lawmakers avoid the cause of these high drug prices. That being the PBM’s. Do they think that the stealing that goes on will go away? Or are the PBM’s paying the lawmakers off to look the other way ?